Trials / Sponsors / Cascadian Therapeutics Inc.
Cascadian Therapeutics Inc.
Industry · 12 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study of the Absorption, Metabolism, and Excretion of Tucatinib in Healthy Participants Healthy | Phase 1 | 2017-12-30 |
| Completed | Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer Advanced Breast Carcinoma, Advanced Ovarian Carcinoma | Phase 1 | 2014-11-01 |
| Completed | Phase 1 Study of ONT-10 in Patients With Solid Tumors Solid Tumors | Phase 1 | 2013-03-01 |
| Completed | Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid Tumors Solid Tumors | Phase 1 | 2012-11-01 |
| Terminated | Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma Advanced BRAF-mutant Cancers | Phase 1 / Phase 2 | 2012-08-01 |
| Completed | Study of the Pharmacokinetics and Pharmacodynamics of Crystalline PX-866 Tablets and Amorphous PX-866 Capsules Healthy Volunteer | Phase 1 | 2011-07-01 |
| Completed | Phase 1 and 2 Study of PX-866 and Cetuximab Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | Phase 1 / Phase 2 | 2010-12-01 |
| Completed | Study of PX-866 and Docetaxel in Solid Tumors Non Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Phase 1 / Phase 2 | 2010-09-01 |
| Completed | A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metasta Metastatic Cancer, Advanced Cancer | Phase 1 | 2008-06-01 |
| Completed | Phase I Trial of Oral PX-866 Advanced Solid Tumors | Phase 1 | 2008-06-01 |
| Completed | Phase I Trial of PX-478 Advanced Solid Tumors, Lymphoma | Phase 1 | 2007-08-01 |
| Terminated | Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer Pancreatic Neoplasms | Phase 2 | 2006-12-01 |